Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001490978-25-000068
Filing Date
2025-05-29
Accepted
2025-05-29 17:24:05
Documents
3
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1748553839.html 3  
1 FORM 3 wk-form3_1748553839.xml 3 1788
2 EX-24 poaccc528.htm EX-24 4802
3 poaccc528001.jpg GRAPHIC 290187
  Complete submission text file 0001490978-25-000068.txt   407771
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1540 BROADWAY, 24TH FLOOR NEW YORK NY 10036
Business Address
Aklian Mannix Vartan (Reporting) CIK: 0002066297 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39206 | Film No.: 251004886